Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company advancing breakthrough therapies for diseases, today announced the deployment of the OpenAI API to support ...

Construction is scheduled to commence in spring 2026, with both facilities anticipated to be fully operational by 2029.

AbbVie invests $380 million to build two new API manufacturing facilities in North Chicago while Bora Pharmaceuticals Co., Ltd. and GSK have renewed a five-year global manufacturing partnership.

Citi Pharma Limited, one of Pakistan’s leading pharmaceutical companies, has approved the launch of an initial public offering (IPO) for its wholly owned subsidiary, Citi Veterinary Pharma Limited.

Morepen Laboratories has secured a multi-year Contract Development and Manufacturing Organisation (CDMO) mandate worth about ...

Part of AbbVie’s vow to invest $100 billion in the U.S. over the next decade, the two Illinois facilities will make active ingredients for next-generation neuroscience and obesity drugs when they ...

Aurobindo Pharma plans to increase Penicillin-G production to over 10,000 metric tonnes annually in the next 12 months. The Hyderabad-based company's strategies aim to improve profitability through ...

Akums Drugs and Pharmaceuticals Ltd (BOM:544222) reports robust growth in CDMO and international segments, while addressing challenges in API pricing and trade generics.

Sudarshan Pharma Industries Limited has announced that it has successfully obtained two significant international certifications for its manufacturing facility located in Hyderabad, Telangana. The ...

Lupin Ranks No. 1 globally in pharma; Tops all sectors in India in S&P ESG Assessment 2025: Our Bureau, Mumbai Friday, February 27, 2026, 11:30 Hrs [IST] Global pharma major Lupin ...

Barclays 43rd Annual Industrial Select Conference February 18, 2026 7:30 AM ESTCompany ParticipantsRussell Becker - ...